Search

everythinglearnresearchcommunity

for

Search:↓

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Juvenile alopecia areata is more severe and has a worse prognosis than maturity-onset alopecia areata.

Different autoantibody groups in pediatric SLE are linked to specific symptoms and disease outcomes.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

Testing for various autoantibodies in Indian children with lupus can help predict disease symptoms and risks.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Valproic acid can cause low platelet counts, especially at high doses or in elderly patients.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Six months after COVID-19, most patients still had autoantibodies.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Alopecia areata involves unique activation of certain immune cells.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Alopecia areata is linked to autoimmune antibodies.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Hair loss treatment caused more hair loss in a man.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.